| A Study of NCS-01 in Patients With Acute Ischemic Stroke (NCT03915431) | NC Medial Research Inc | 2020-02-27 |
| A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer (NCT04236362) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-02-27 |
| A First-in-Human Study of CEE321 in Adult Subjects (NCT04612062) | Novartis Pharmaceuticals | 2020-02-27 |
| Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production (NCT04268953) | Cerecin | 2020-02-27 |
| Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants (NCT04271488) | Eisai Co., Ltd. | 2020-02-27 |
| Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome (NCT04185220) | National Cancer Institute (NCI) | 2020-02-26 |
| Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma (NCT04214392) | City of Hope Medical Center | 2020-02-26 |
| A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function (NCT04237831) | Bristol-Myers Squibb | 2020-02-26 |
| Imatinib for Pain in Sickle Cell Anemia (NCT03997903) | Indiana University | 2020-02-26 |
| Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. (NCT04291209) | Sunnybrook Health Sciences Centre | 2020-02-26 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age (NCT04188964) | Kyowa Kirin Pharmaceutical Development Ltd | 2020-02-26 |
| Lu AF28996 in Participants With Parkinson's Disease (PD) (NCT04291859) | H. Lundbeck A/S | 2020-02-26 |
| Gait Speeds and Demands in Chronic Stroke Patients: A Multi-dimensional Investigation (NCT04436536) | National Cheng Kung University | 2020-02-26 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor (NCT04906434) | Abbisko Therapeutics Co, Ltd | 2020-02-26 |
| Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions (NCT04324294) | Cedars-Sinai Medical Center | 2020-02-26 |
| A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants (NCT04172987) | Eli Lilly and Company | 2020-02-26 |
| TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma (NCT04217473) | TILT Biotherapeutics Ltd. | 2020-02-26 |
| A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time (NCT04263350) | Bristol-Myers Squibb | 2020-02-26 |
| Mass Balance Study of [14C]LC350189 in Healthy Volunteers (NCT04070846) | LG Chem | 2020-02-26 |
| A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics (NCT03843502) | University of Florida | 2020-02-26 |
| ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer (NCT04267939) | Bayer | 2020-02-26 |
| Prevention of Breast Cancer-related Lymphedma With Tacrolimus (NCT04390685) | Odense University Hospital | 2020-02-26 |
| Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors (NCT04262466) | Immunocore Ltd | 2020-02-25 |
| A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps (NCT04276207) | Eli Lilly and Company | 2020-02-25 |
| Magnesium Replacement and Hyperglycemia After Kidney Transplantation (NCT04382157) | Oslo University Hospital | 2020-02-25 |
| A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers (NCT04328844) | iOnctura | 2020-02-25 |
| Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (NCT04253561) | SOLTI Breast Cancer Research Group | 2020-02-25 |
| Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) (NCT04120883) | University of Michigan | 2020-02-25 |
| D2C7-IT With Atezolizumab for Recurrent Gliomas (NCT04160494) | Darell Bigner | 2020-02-25 |
| The Effect of Preoperative Antibiotics on Peri-implant Healing (NCT04280406) | Université de Montréal | 2020-02-25 |
| Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy (NCT04181255) | University of Michigan | 2020-02-25 |
| Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer (NCT04005144) | University of California, San Francisco | 2020-02-25 |
| A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body (NCT04232839) | Boehringer Ingelheim | 2020-02-25 |
| Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects (NCT04415645) | Vivozon, Inc. | 2020-02-24 |
| SP16 Inflammatory Response Inhibition Trial (NCT04225533) | Serpin Pharma, LLC | 2020-02-24 |
| Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers (NCT04210752) | EyeGene Inc. | 2020-02-24 |
| A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome (NCT04259281) | Ultragenyx Pharmaceutical Inc | 2020-02-24 |
| A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396 (NCT04246190) | Chong Kun Dang Pharmaceutical | 2020-02-24 |
| Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects (NCT04297865) | HK inno.N Corporation | 2020-02-24 |
| A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis (NCT04121468) | The Hospital for Sick Children | 2020-02-24 |
| A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (NCT04050553) | Eli Lilly and Company | 2020-02-24 |
| A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil (NCT04283136) | UCB Biopharma SRL | 2020-02-24 |
| A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors (NCT04278144) | Bolt Biotherapeutics, Inc. | 2020-02-24 |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols (NCT04299880) | Sumitomo Pharma America, Inc. | 2020-02-24 |
| Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers (NCT04526496) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2020-02-24 |
| Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors (NCT04142931) | Dr. Ronnie Shapira | 2020-02-24 |
| Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 (NCT04144140) | Eisai Inc. | 2020-02-24 |
| SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus (NCT04201496) | Ananda Basu, MD | 2020-02-24 |
| Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD (NCT04213248) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2020-02-21 |
| A Study of the Effects of Food and Age on Danicopan (NCT04551599) | Alexion Pharmaceuticals, Inc. | 2020-02-21 |
| A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 (NCT04324996) | Chongqing Public Health Medical Center | 2020-02-21 |
| Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment (NCT04262336) | Decibel Therapeutics | 2020-02-21 |
| A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma (NCT04108195) | Janssen Research & Development, LLC | 2020-02-21 |
| A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients (NCT05075304) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2020-02-21 |
| A Noval Tau Tracer in Young Onset Dementia (NCT04248270) | Chang Gung Memorial Hospital | 2020-02-20 |
| Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer (NCT04348643) | Chongqing Precision Biotech Co., Ltd | 2020-02-20 |
| Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT (NCT04284228) | NexImmune Inc. | 2020-02-20 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers (NCT04268784) | Denali Therapeutics Inc. | 2020-02-20 |
| Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (NCT04280328) | Corvus Pharmaceuticals, Inc. | 2020-02-20 |
| A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants (NCT04277624) | Astellas Pharma Global Development, Inc. | 2020-02-20 |
| To Study the Pathophysiological Features of Multiple Sclerosis (NCT04242056) | Chang Gung Memorial Hospital | 2020-02-20 |
| Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants (NCT04269538) | Telavant, Inc. | 2020-02-19 |
| Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL (NCT04155710) | Iovance Biotherapeutics, Inc. | 2020-02-19 |
| Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female Subjects (NCT04265911) | Affinivax, Inc. | 2020-02-19 |
| Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer (NCT03932409) | University of Oklahoma | 2020-02-19 |
| Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites (NCT04310085) | Medicines for Malaria Venture | 2020-02-19 |
| Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease (NCT04482179) | University of Pennsylvania | 2020-02-19 |
| Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM (NCT03961971) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-18 |
| Real-time Intraoperative Breast Cancer Visualization for Margin Assessment (NCT02807597) | Samuel Achilefu | 2020-02-18 |
| A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants (NCT04282746) | Janssen Research & Development, LLC | 2020-02-18 |
| Safety and Immunogenicity of a Nipah Virus Vaccine (NCT04199169) | Auro Vaccines LLC | 2020-02-18 |
| A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body (NCT04267276) | Boehringer Ingelheim | 2020-02-18 |
| Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2 (NCT04222985) | Sanofi Pasteur, a Sanofi Company | 2020-02-18 |
| A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870 (NCT04241965) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2020-02-18 |
| Desensitization in Kidney Allograft Using Daratumumab (NCT04204980) | Assistance Publique - Hôpitaux de Paris | 2020-02-18 |
| Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants (NCT04269356) | Bristol-Myers Squibb | 2020-02-18 |
| First-In-Human Study of EOS884448 in Participants with Advanced Cancers. (NCT04335253) | iTeos Therapeutics | 2020-02-18 |
| ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors (NCT04205227) | ENB Therapeutics, Inc | 2020-02-18 |
| Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers (NCT04252833) | Lotus Clinical Research, LLC | 2020-02-18 |
| Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma (NCT04004442) | University of Oklahoma | 2020-02-17 |
| A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD) (NCT04262791) | AbbVie | 2020-02-17 |
| A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants (NCT04234672) | Neurocrine Biosciences | 2020-02-17 |
| A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants (NCT04220801) | Shanghai Zhimeng Biopharma, Inc. | 2020-02-17 |
| A Study of LY3478006 in Healthy Participants (NCT04230122) | Eli Lilly and Company | 2020-02-17 |
| Chemoprophylactic Activity of M5717 in PfSPZ Challenge Model (NCT04250363) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2020-02-17 |
| Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. (NCT04109482) | Mustang Bio | 2020-02-17 |
| Safety and Immunogenicity of a Chlamydia Vaccine CTH522 (NCT03926728) | Statens Serum Institut | 2020-02-17 |
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists (NCT04183192) | Food and Drug Administration (FDA) | 2020-02-17 |
| Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567 (NCT06030375) | Novakand Pharma AB | 2020-02-17 |
| The Effects of Platelet-Rich Plasma Versus Prolotherapy On Rotator Cuff Tendinopathy: A Randomized Controlled Trial. (NCT04640662) | University of Malaya | 2020-02-17 |
| Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions (NCT05136521) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2020-02-17 |
| Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors (NCT04249843) | MapKure, LLC | 2020-02-17 |
| First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes (NCT04259801) | Novo Nordisk A/S | 2020-02-17 |
| BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations (NCT03914742) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-16 |
| Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants (NCT04265781) | Bayer | 2020-02-15 |
| NK Cells Treatment for COVID-19 (NCT04280224) | Henan Medical University | 2020-02-15 |
| MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma (NCT03773744) | Turnstone Biologics, Corp. | 2020-02-15 |
| A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia (NCT04276987) | Ruijin Hospital | 2020-02-15 |
| Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose. (NCT04288518) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2020-02-15 |
| A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer (NCT04264936) | Peking University Cancer Hospital & Institute | 2020-02-15 |